Fluidigm FLDM 深 沪
已收盘 04-05 16:00:00 美东时间
3.71
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 3.71
- 总市值 2.86亿
- 52周最高 7.51
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.67
- 委 比 0.00%
- 总股本 7719.86万
- 历史最高 49.455
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.17
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Standard BioTools Completes Sale of SomaLogic to Illumina
Standard BioTools completed the sale of SomaLogic to Illumina for $350 million upfront, plus up to $75 million in earnouts and royalties. The transaction enhances the company's financial position, with $550 million in cash to fuel M&A growth. CEO Michael Egholm highlighted the strategic transformation and strengthened financial standing. The deal includes IP licenses and royalty streams, positioning the company for future expansion.
01-30 14:09
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
Standard BioTools Inc. reported preliminary, unaudited 2025 revenue of approximately $185 million for the combined company and $85 million from continuing operations, exceeding expectations. CEO Michael Egholm highlighted steady execution, cost optimization, and a focus on profitability amid macro challenges. The company expects to close the sale of SomaLogic to Illumina in the first half of 2026, resulting in $550 million in cash and a stronger ...
01-08 12:00
Standard BioTools Get a Buy Rating, Analyst Cites Unique Technology, Management and Board
KeyBanc Capital Markets initiated coverage on Standard BioTools Inc (NASDAQ: LAB) with an Overweight rating and a
2023-07-13 01:58
Standard Biotools Inc盘中异动 急速拉升5.03%报1.78美元
北京时间2022年07月08日00时01分，Standard Biotools Inc（LAB.us）股票出现异动，股价快速拉升5.03%。截至发稿，该股报1...
2022-07-08 01:08
Fluidigm宣布与Caligan Partners达成支持协议，涉及Casdin Capital和Viking Global的2.5亿美元战略资本注入
Caligan Partners to Vote "FOR" Casdin and Viking Transaction and All Other Flui...
2022-03-29 21:31
Fluidigm强调Casdin Capital和Viking Global的战略注资是唯一可行的融资解决方案
Company Urges ALL Stockholders to Vote "FOR" the Proposals at the Special Meeti...
2022-03-28 20:38
Fluidigm将股东特别会议延期至2022年4月1日
Provides Stockholders Additional Time to Consider $250 Million Strategic Capita...
2022-03-26 04:06
领先的独立代理咨询公司ISS和Glass Lewis建议Fluidigm股东投票支持与2.5亿美元战略资本注入有关的所有提案
Fluidigm Board of Directors Unanimously Recommends Stockholders Vote "FOR" ALL ...
2022-03-18 06:02
Fluidigm公司宣布与阿布扎比干细胞中心达成合作协议，以加快成像质谱技术在定向干细胞疗法开发中的应用
Collaboration Enables Further Expansion of Mass Cytometry in the Middle East SO...
2022-02-17 21:37
Fluidigm公司宣布2021年第四季度和全年的初步收入超过指导
Fourth quarter preliminary revenue of $38.0 to $38.3 million Full year 2021 pre...
2022-01-11 21:07
